Phase 2 Ovarian Cancer Trial, Not Yet Recruiting NCT07068178 Sponsor: Jing Li Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 2 Ovarian Cancer Trial, Not Yet Recruiting

NCT07068178
Not Yet Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a specific type of advanced ovarian cancer (high-grade serous ovarian adenocarcinoma, at stage IIIC or IVA), confirmed by a tissue sample test.
  • You are between 18 and 70 years old.
  • Your doctors expect you to live for at least 12 more months.
  • You have received a specific score from two specialist doctors after a keyhole surgery assessment, suggesting surgery to remove all the cancer may be difficult (confirm with trial site).
  • Your liver is working well enough, based on blood test results showing normal or near-normal liver enzyme and bilirubin levels.
  • Your kidneys are working well enough, based on a normal or near-normal creatinine level in your blood.
  • Your blood counts are healthy enough, meaning your red blood cells, white blood cells, platelets, and infection-fighting cells are all above certain minimum levels.
  • You are generally well enough to carry out daily activities with little or no limitation (rated 0 or 1 on a standard health scale).

Who may not be able to join:

  • You have a full or partial blockage in your bowel.
  • You have an abnormal opening or channel in your intestine (an intestinal fistula).
  • You have a blocked kidney that has not been relieved by placing a small tube (stent) in the ureter.
  • You have previously had an organ transplant.
  • You have inflammatory bowel disease (such as Crohn's disease or ulcerative colitis).
  • You have, or have had, an autoimmune disease (a condition where the immune system attacks the body, such as lupus).
  • You have previously received immunotherapy or drugs that affect the immune system.
  • The cancer has spread to your brain.
  • You have had a serious blood clot in a vein (grade 3 or higher) (confirm with trial site).
  • You currently have an active infection, such as tuberculosis.
  • You have previously had radiotherapy to your pelvis or abdomen.
  • You have previously had a treatment called HIPEC (heated chemotherapy delivered directly into the abdomen) or similar heat-based therapy.
  • You have significant problems with a major organ such as your heart, liver, or kidneys (grade 2 or above) (confirm with trial site).
  • You have been diagnosed with another cancer in the last 5 years, unless it was a skin cancer or thyroid cancer.
  • You have a psychiatric or mental health condition that might make it difficult to follow the trial requirements.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Sponsor
Jing Li
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 May 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

R0 Resection Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov